SAUTEBIN, LIDIA
 Distribuzione geografica
Continente #
AS - Asia 5.369
NA - Nord America 4.800
EU - Europa 3.545
SA - Sud America 596
AF - Africa 104
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.431
Nazione #
US - Stati Uniti d'America 4.629
SG - Singapore 2.510
RU - Federazione Russa 1.460
CN - Cina 940
VN - Vietnam 891
HK - Hong Kong 541
BR - Brasile 474
UA - Ucraina 421
IT - Italia 397
FR - Francia 271
DE - Germania 256
FI - Finlandia 218
IE - Irlanda 156
CA - Canada 101
JP - Giappone 91
GB - Regno Unito 83
SE - Svezia 82
NL - Olanda 77
IN - India 75
IQ - Iraq 48
BD - Bangladesh 46
AR - Argentina 39
MX - Messico 35
TR - Turchia 34
TH - Thailandia 27
RS - Serbia 26
CI - Costa d'Avorio 24
ID - Indonesia 24
EC - Ecuador 21
PL - Polonia 21
ZA - Sudafrica 21
ES - Italia 19
PH - Filippine 19
AT - Austria 18
VE - Venezuela 16
CO - Colombia 12
PK - Pakistan 12
TW - Taiwan 12
JM - Giamaica 10
MY - Malesia 10
PY - Paraguay 10
CL - Cile 9
RO - Romania 9
KR - Corea 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AU - Australia 7
JO - Giordania 7
MA - Marocco 7
AZ - Azerbaigian 6
BO - Bolivia 6
IL - Israele 6
IR - Iran 6
KE - Kenya 6
PE - Perù 6
BG - Bulgaria 5
LB - Libano 5
TN - Tunisia 5
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
PT - Portogallo 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LY - Libia 3
NG - Nigeria 3
PS - Palestinian Territory 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BS - Bahamas 2
CD - Congo 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SO - Somalia 2
TG - Togo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
Totale 14.392
Città #
Singapore 1.095
San Jose 598
Hong Kong 519
Jacksonville 390
Chandler 377
Moscow 341
Beijing 264
Santa Clara 261
Ho Chi Minh City 221
Ashburn 216
Millbury 213
Hanoi 183
Princeton 180
The Dalles 168
Dong Ket 162
Lauterbourg 150
Council Bluffs 124
Nanjing 108
Los Angeles 107
Boston 101
Buffalo 90
Wilmington 87
Tokyo 79
Amsterdam 62
Naples 59
New York 58
Ottawa 54
Roubaix 45
Dallas 42
Nanchang 39
Hebei 36
Redondo Beach 36
São Paulo 36
Woodbridge 35
Munich 34
Orem 33
Da Nang 31
Seattle 31
Shenyang 31
Des Moines 30
Haiphong 30
Helsinki 25
Norwalk 25
Tianjin 25
Belgrade 23
Jiaxing 23
Brooklyn 22
Mexico City 20
Nuremberg 20
Rome 20
Houston 18
Kronberg 18
Napoli 18
Baghdad 17
Chennai 17
Chicago 17
Hefei 17
Milan 17
Changsha 15
Hải Dương 14
Brasília 12
Denver 12
Falls Church 12
Istanbul 12
Johannesburg 12
Redwood City 12
Rio de Janeiro 12
San Francisco 12
Turku 12
Warsaw 12
Biên Hòa 11
Boardman 11
London 11
Atlanta 10
Hangzhou 10
Montreal 10
Orange 10
Tübingen 10
Bangkok 9
Belo Horizonte 9
Florence 9
Frankfurt am Main 9
Indiana 9
Phoenix 9
Toronto 9
Guangzhou 8
Hanover 8
Ninh Bình 8
Quận Bình Thạnh 8
Campinas 7
Falkenstein 7
Guarulhos 7
Kingston 7
Kunming 7
Miami 7
Quito 7
Stockholm 7
Tashkent 7
Amman 6
Augusta 6
Totale 7.500
Nome #
Regulation (EC) No. 1223/2009 on cosmetic products ('Cosmetics Regulation'): the European Cosmetovigilance System. Serious Undesirable Effects Reporting Guidelines and notification Forms 162
Capitolo 42 del Trattato di Farmacologia. Farmaci per la terapia della gotta 151
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO PLEURISY AND LUNG INJURY CAUSED BY CARRAGEENAN. 147
BRP-7, a novel benzimidazole-based chemotype targeting 5-lipoxygenase-activating protein, inhibits leukotriene biosynthesis in experimental models of acute inflammation in vivo. 147
Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids 145
In vivo differences in leukotriene biosynthesis in zymosan-induced peritonitis: role of resident peritoneal macrophages. 133
BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly 132
5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration 131
On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficiency in vivo. 128
The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). 128
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 126
Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats 125
Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors 124
5-ARYLIDENE-2-IMINO-4-THIAZOLIDINONES: DESIGN AND SYNTHESIS OF NOVEL ANTI-INFLAMMATORY AGENTS. 123
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO ACUTE PANCREATITIS INDUCED BY CERULEIN. 123
SAR Studies on Curcumin's Pro-inflammatory Targets: Discovery of Prenylated Pyrazolocurcuminoids as Potent and Selective Novel Inhibitors of 5-Lipoxygenase. 123
In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. 121
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 120
1,5-DIARYLPYRROLE-3-ACETIC ACIDS AND ESTERS AS NOVEL CLASSES OF POTENT AND HIGHLY ELECTIVE CYCLOOXYGENASE-2 INHIBITORS. 118
SLOW REACTING SUBSTANCE OF ANAPHYLAXIS ENHANCES THE GENERATION OF 12 L HYDROXY 5,8,10,14 EICOSATETRAENOIC ACID IN ISOLATED LUNGS. 118
Inhibition of inducible Nitric Oxide Synthase expression by an acetonic extract from Feijoa sellowiana Berg. fruits. 118
Anti-inflammatory activity of macrolide antibiotics. 118
IDENTIFICATION AND PARTIAL PURIFICATION OF AN ENDOTHELIAL-DERIVED RELAXING FACTOR(S) IN SERUM OF HYPERTENSIVE PREECLAMPTIC PARTURIENTS. 117
EPIDEMIOLOGICAL STUDIES ON DIETARY LIPIDS,HUMAN PLASMA LIPIDS AND PLATELET LIPIDS AND FUNCTION. 114
HYDROGEN SULPHIDE-INDUCED MOUESE PAW EDEMA INVOLVES PHOSPHOLIPASE A2 ACTIVATION 114
LEUKOTRIENES IN HUMAN LUNG: FORMATION AND BINDING SITES. 113
ANTINFIAMMATORI NON STEROIDEI 113
The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo 113
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 113
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 112
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO SPLANCHNIC ARTERY OCCLUSION SHOCK. 111
ARACHIDONIC ACID METABOLISM AND CYCLIC NUCLEOTIDES IN THE CNS DURING HYPOXIA. 110
Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2 110
Flow synthesis and biological studies of an analgesic adamantane derivative that inhibits P2X7-evoked glutamate release 110
Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. 109
LIPOCORTIN AND VASOCORTIN: TWO SPECIES OF GLUCOCORTICOID INDUCED PROTEINS AFFECTING VASCULAR PERMEABILITY. 108
Synthesis and structure-activity of antisense peptides corresponding to the region for CaM-binding domain of the inducible nitric oxide synthase 107
ROLE OF NITRIC OXIDE ON MULTIPLE ORGANE FAILURE INDUCED BY ZYMOSAN. 105
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression 104
Hydrogen sulphide-induced mouse paw edema involves phospholipase A2 activation. 104
NITRIC OXIDE INHIBITS LEUKOCYTES MIGRATION IN RAT DERMAL PASSIVE ARTHUS REACTION AND CARRAGEENAN PLEURISY. 103
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring CholesterolEsterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo. CO-FIRST AUTHOR 103
Oxalomalate affects the inducible nitric oxide synthase expression and activity 102
The role of 5-lipoxygenase and leukotrienes in shock and ischemia-reperfusion injury. 101
HEALING POWER OF ALOES 100
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. 97
Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage 96
CONVERSION OF ARACHIDONIC ACID BY LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITIES: QUALITATIVE AND QUANTITATIVE ASPECTS. 95
The 5-lipoxygenase inhibitor zileuton inhibits prostaglandin production by reducing arachidonic acid release: in vitro and in vivo effects. 95
Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. 94
Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-gamma 91
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase 91
17BETA-ESTRADIOL ANTINFLAMMATORY ACTIVITY IN CARRAGEENIN-INDUCED PLEURISY. 89
STIMULUS RELATED DIFFERENCES IN THE FORMATION FORMATION OF LEUKOTRIENES AND PGD2 AFTER IMMUNOLOGICAL AND NON IMMUNOLOGICAL CHALLENGE OF HUMAN LUNG PARENCHIMA "IN VITRO". 88
The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. 87
“La segnalazione degli eventi indesiderabili secondo il Regolamento (CE) n. 1223/2009: le linee guida e le schede di segnalazione” 87
A MASS FRAGMENTOGRAPHIC PROCEDURE FOR THE SIMULTANEOUS DETERMINATION OF HETE AND PGF2 IN THE CENTRAL NERVOUS SYSTEM. 86
Healing powers of aloes 86
Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo. 86
Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. 85
Relaxant effect of capsazepine in the isolated rat ileum 84
A cosmetovigilance survey in Europe. 83
INVOLVEMENT OF NF-KB IN THE REGULATION OF CYCLOOXIGENASE-2 PROTEIN EXPRESSION IN LPS-STIMULATED J774 MACROPHAGES. 83
THE ROLE OF THE PHENETHYLE ESTER OF CAFFEIC ACID ( CAPE) IN THE INHIBITION OF RAT LUNG CYCLOOXYGENASE ACTIVITY BY PROPOLIS. 82
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males 82
ROLE OF 5-LIPOXYGENASE IN THE MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN. 81
EFFECTS OF WATER DEPRIVATION AND ANGIOTENSIN II INTRACEREBROVENTRICULAR ADMINISTRATIONON BRAIN NITRIC OXIDE SYNTHASE ACTIVITY. 81
REGULATION OF PROSTAGLANDIN GENERATION IN CARRAGEENAN-INDUCED PLEURISY BY INDUCIBLE NITRIC OXIDE SYNTHASE IN KNOCKOUT MICE 81
Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase. 81
Inhibition of microsomal prostaglandin E(2) synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. 81
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alfa by lipopolysaccharide-activated J774 macrophages. 80
EFFECT OF THE B2-ADRENERGIC AGONIST FENOTEROL ON THE RELEASE OF LEUKOTRIENES AND PROSTAGLANDIN D2 FROM HUMAN LUNG PARENCHIMA. 80
PGF2A,THROMBOXANE B2 AND HETE LEVELS IN GERBIL BRAIN CORTEX AFTER LIGATION OF COMMON CAROTID ARTERIES AND DECAPITATION. 80
Lipocortins 80
Interaction between nitric oxide and prostaglandins in inflammation. 80
Analysis of toxic exposures to cosmetic products through the data base of the Poison Control Centre of the Niguarda Ca’ Granda Hospital 80
“Il nuovo sistema di Cosmetovigilanza secondo il Regolamento 1223/2009: le iniziative del Ministero della Salute” 80
CONGENITAL DEFICIENCY OF THROMBOXANE AND PROSTACYCLIN. 79
ANALYSIS OF CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS IN INCUBATION MEDIA. 79
THE MODE OF ACTION OF TIARAMIDE HYDROCHLORIDE:A NEW ANTIASTHMATIC DRUG. 79
ANALYTICAL PROCEDURES FOR THE STUDY OF ARACHIDONIC ACID METABOLISM IN PLATELETS AND BRAIN. 79
"I cosmetici contraffatti e il loro impatto sulla sicurezza d’uso e sulla salute dei consumatori. Ruolo della sorveglianza e della vigilanza” 79
PROSTAGLANDINE E OSSIDO D'AZOTO COME BERSAGLI MOLECOLARI PER LA TERAPIA ANTINFIAMMATORIA 78
Cosmetovigilance survey: are cosmetics considered safe by consumers? 77
ARACHIDONIC ACID METABOLISM IN THE LUNGS: EFFECT OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS. 77
Cinnamyl-3,4-Dihydroxy-{alpha}-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase. 77
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase 77
FOOD DEPRIVATION INCREASES BRAIN NITRIC OXIDE SYNTHASE AN DEPRESSES BRAIN SEROTONIN LEVELS IN RATS. 76
USE OF TRITIUM LABELED AMINO ACID CONJUGATES OF PROSTAGLANDINS AND THROMBOXANE AS LABELED LIGANDS IN PROSTANOID RADIOIMMUNOASSAY. 75
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. 75
PROTECTIVE EFFECTS OF ANTHOCYANINS FROM BLACKBERRY IN A RAT MODEL OF ACUTE LUNG INFLAMMATION. 74
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity inJ774 macrophages 74
REGULATION OF PROSTAGLANDINS PRODUCTION BY INHIBITION OF POLY(ADP-RIBOSE) SYNTHASE IN CARRAGEENIN-INDUCED PLEURISY. 73
RELEASE OF LEUKOTRIENS, INDUCED BY THE CA++-IONOPHORE A23187,FROM HUMAN LUNG PARENCHIMA. 73
Gender-specific regulation of 5-lipoxygenase 73
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52) - a novel type 5-lipoxygenase inhibitor with favorable molecular pharmacology and efficacy in vivo. 73
Adverse cosmetic events: a pilot project 72
Modulazione della via della 5-lipossigenasi da parte dei glucocorticoidi, vecchi e nuovi, “in vitro” ed in modelli “in vivo” di patologie infiammatorie/autoimmuni: ruolo della leucine-zipper indotta dai glucocorticoidi (GILZ) e delle proteine chinasi attivate dal mitogeno (MAPK) 72
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 72
SELECTIVE INHIBITION BY VASOCORTIN OF HISTAMINE RELEASE INDUCED BY DEXTRAN AND CONCAVALIN-A FROM RAT PERITONEAL CELLS. 71
Totale 9.823
Categoria #
all - tutte 51.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022975 13 8 6 16 1 35 15 46 172 42 202 419
2022/2023805 235 87 39 41 79 80 0 52 98 57 26 11
2023/2024534 17 87 64 27 17 19 5 64 6 9 163 56
2024/20253.687 243 308 23 31 62 239 436 188 361 383 1.079 334
2025/20266.242 720 421 608 411 1.074 211 726 499 856 450 140 126
2026/202776 76 0 0 0 0 0 0 0 0 0 0 0
Totale 14.644